- Home
- PRLD vs RECT Comparison
PRLD vs RECT Comparison
Compare PRLD & RECT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- RECT
- Stock Information
- Founded
- PRLD 2016
- RECT 1997
- Country
- PRLD United States
- RECT Singapore
- Employees
- PRLD N/A
- RECT N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- RECT
- Sector
- PRLD Health Care
- RECT
- Exchange
- PRLD Nasdaq
- RECT Nasdaq
- Market Cap
- PRLD 73.7M
- RECT N/A
- IPO Year
- PRLD 2020
- RECT 2024
- Fundamental
- Price
- PRLD $0.82
- RECT $4.11
- Analyst Decision
- PRLD Strong Buy
- RECT
- Analyst Count
- PRLD 2
- RECT 0
- Target Price
- PRLD $4.50
- RECT N/A
- AVG Volume (30 Days)
- PRLD 201.7K
- RECT 12.9K
- Earning Date
- PRLD 03-10-2025
- RECT 03-27-2025
- Dividend Yield
- PRLD N/A
- RECT N/A
- EPS Growth
- PRLD N/A
- RECT N/A
- EPS
- PRLD N/A
- RECT 0.14
- Revenue
- PRLD $7,000,000.00
- RECT $33,502,767.00
- Revenue This Year
- PRLD N/A
- RECT N/A
- Revenue Next Year
- PRLD N/A
- RECT N/A
- P/E Ratio
- PRLD N/A
- RECT $28.81
- Revenue Growth
- PRLD N/A
- RECT 8.42
- 52 Week Low
- PRLD $0.63
- RECT $2.70
- 52 Week High
- PRLD $6.80
- RECT $7.68
- Technical
- Relative Strength Index (RSI)
- PRLD 56.29
- RECT N/A
- Support Level
- PRLD $0.71
- RECT N/A
- Resistance Level
- PRLD $0.76
- RECT N/A
- Average True Range (ATR)
- PRLD 0.07
- RECT 0.00
- MACD
- PRLD 0.02
- RECT 0.00
- Stochastic Oscillator
- PRLD 87.50
- RECT 0.00
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.